The increased demand is driven by the rising prevalence of obesity and type 2 diabetes and the growing popularity of GLP-1 agonist medications as weight loss treatments
With our patent-pending cell signaling technology, InCelligence Complex, we go further than simple nourishment to apply the latest research into biochemical pathways that support the bodys natural processes
It is generally limited to clinical trial or approved research channels
Still, to ensure high standards of care and hygiene, only donate at accredited centers
Enhanced Memory Formation and Information Recall*
One randomized, double-blind, three-year trial comparing pioglitazone to glyburide as add-on to metformin and insulin therapy was specifically designed to evaluate the incidence of serum ALT elevation to greater than three times the upper limit of the reference range, measured every eight weeks for the first 48 weeks of the trial then every 12 weeks thereafter